View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Gilat Awarded $5 Million Order from the US Department of Defense

Gilat Awarded $5 Million Order from the US Department of Defense Gilat to provide DKET 3421 terminals for easy-to-deploy transportable satcom network hubs PETAH TIKVA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that the US Department of Defense awarded another $5 million order to one of the company’s US-based subsidiaries, DataPath. This additional order is for DKET 3421 terminals, transportable satcom hubs that deliver the operational...

 PRESS RELEASE

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Fi...

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and leveraging the company’s promising research platform for tumor-activated bispecific and cell engager molecules Reports additional Phase 2 data for XTX202, a tumor-activated, beta-gamma biased IL-2, supporting potential as combination therapy; plans to discontinue monotherapy development and evaluate collaboration op...

 PRESS RELEASE

Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spid...

Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI"). Researchers at RPI published a paper in Microbial Cell Factories outlining a new and novel method of creating spider silk protein from waste plastics. This project used a new strain of Pseudomonas bacteria capable of converting depolymerized p...

 PRESS RELEASE

Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Res...

Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results Shimmick realized significant progress with 24% growth in Shimmick Projects, with gross margin of 7% IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial results for the fiscal year ended December 29, 2023. Fiscal Year 2023 Highlights Completed Initial Public Offering in November 2023Reported revenue of $633 million, which includes $434 million of Shimmick Projects revenue, an increase of 24% for fiscal y...

 PRESS RELEASE

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial...

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003 (intranasal 5-MeO-DMT) Phase 2a open-label results demonstrated a rapid and durable antidepressant effect through three months in TRD patients; top-line results from a controlled Phase 2b TRD study anticipated in 2H 2024Dosing commenced in VLS-01 (oral transmucosal DMT) P...

 PRESS RELEASE

Total voting rights

Total voting rights 28 MARCH 2024 NORTHERN VENTURE TRUST PLC TOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern Venture Trust PLC (“the Company”) notifies the market that the capital of the Company as at 28 March 2024 consists of 190,460,878 ordinary shares with a nominal value of 25p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 190,460,878 (“the Figure”). The Figure may be use...

 PRESS RELEASE

Total voting rights

Total voting rights 28 MARCH 2024 NORTHERN 2 VCT PLC TOTAL VOTING RIGHTS  In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern 2 VCT PLC (the “Company”) notifies the market that the capital of the Company as at 28 March 2024 consists of 208,675,544 ordinary shares with a nominal value of 5p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 208,675,544 (“the Figure”). The Figure may be used by a sharehol...

 PRESS RELEASE

Total voting rights

Total voting rights 28 MARCH 2024 NORTHERN 3 VCT PLC TOTAL VOTING RIGHTS   In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern 3 VCT PLC (the “Company”) notifies the market that the capital of the Company as at 28 March 2024 consists of 137,164,335 ordinary shares with a nominal value of 5p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 137,164,335 (“the Figure”). The Figure may be used by a shareho...

 PRESS RELEASE

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financia...

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results --Resubmission of NDA On Track for Early Q2 24— --Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported fina...

 PRESS RELEASE

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and...

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates Company continues to evaluate strategic options to maximize shareholder value MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced financial results for the fourth quarter and year ended December 31, 2023 and provided recent corporate updates. "As a result of last year’s FDA r...

 PRESS RELEASE

Aya Gold & Silver: Record 2023 Production, Revenue and Operating Cash ...

Aya Gold & Silver: Record 2023 Production, Revenue and Operating Cash Flow Announces 2024 Guidance MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA, OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce financial and operational results for the fourth quarter and year ended December 31, 2023. All amounts are in US dollars, unless otherwise stated. Annual Highlights Exceeded 2023 production guidance with silver production of 1.97 million ounces (“oz”), a 5% increase from 2022.Ore processed of 281,634 tonnes (“t”) in 2023, a 10% increase from 254...

 PRESS RELEASE

Aya Or & Argent annonce une production, des revenus et des flux de tré...

Aya Or & Argent annonce une production, des revenus et des flux de trésorerie d’exploitation records en 2023 et présente ses prévisions pour 2024 MONTRÉAL, 28 mars 2024 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA, OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer ses résultats financiers et opérationnels pour le quatrième trimestre et l’exercice terminés le 31 décembre 2023. Tous les montants sont en dollars américains à moins d’indication contraire. Faits saillants annuels Dépassement de la production prévue pour 2023 avec une production de 1,97 million d’onces...

 PRESS RELEASE

Tulikivi Corporation’s annual report for 2023 has been published

Tulikivi Corporation’s annual report for 2023 has been published TULIKIVI CORPORATION  STOCK EXCHANGE RELEASE  28 MARCH 2024 AT 13:00 The Tulikivi Corporation annual report for 2023 includes the company's financial statements for 2023 and the auditors' report, the Board of Directors' report, the corporate governance statement and the remuneration report. Tulikivi Corporation has published its financial statements in the XHTML format compliant with the European Single Electronic Format (ESEF) reporting requirements. In accordance with the ESEF requirements, the main statements in the con...

 PRESS RELEASE

Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results o...

Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024 NEW YORK and LEAMINGTON, Ontario, March 28, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its third quarter ended February 29, 2024, on April 9, 2024. Live Audio Webcast Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilr...

 PRESS RELEASE

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR ...

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024 NT219 found to suppress cancer stem cells that promote drug resistance to KRASG12C and KRASG12D inhibitors and solid tumor recurrence Potential biomarkers for treatment with NT219 detected in responding patients in Phase 1 REHOVOT, Israel, March 28, 2024 (GLOBE NEWSWIRE) --   ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today annou...

 PRESS RELEASE

Mayfair Gold Commences 2024 Environmental Field Program at Fenn-Gib Go...

Mayfair Gold Commences 2024 Environmental Field Program at Fenn-Gib Gold Project MATHESON, Ontario, March 28, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today announced the start the 2024 environmental field program in support of a potential environmental assessment for the 100% controlled Fenn-Gib project in the Timmins region of Ontario. The program is being managed by a multi-disciplinary group led by Environmental Applications Group Inc. of Sudbury, Ontario. Mayfair’s president and CEO, Patrick Evans, commented: “This represent...

 PRESS RELEASE

ARKO Corp. Negotiates Enhanced Value for Stockholders in Final Payment...

ARKO Corp. Negotiates Enhanced Value for Stockholders in Final Payment for TEG Acquisition RICHMOND, Va., March 28, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, announced today that it has negotiated improved deferred payment terms and value related to the Company’s previously reported acquisition of the assets of Transit Energy Group and its affiliates (“TEG”). As previously disclosed, on March 1, 2023, the Company closed on the acquisition from TEG of 135 co...

 PRESS RELEASE

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Co...

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. The presentation is scheduled to begin at 3:45 p.m. Eastern Time on Tuesday, April 9, 2024. A link to the live audio webcast, as well as a replay of this event, will be available on the Company’s website under the Investors...

 PRESS RELEASE

Canadian Metals renforce son conseil d'administration avec la nominati...

Montréal, Québec--(Newsfile Corp. - 28 mars 2024) - Canadian Metals Inc. (CSE: CME) (« CME » ou « la Société) est heureuse d'annoncer la nomination de Quentin Yarie, géo, à titre d'administrateur et de président du conseil d'administration. De plus, Michel Gagnon a quitté ses fonctions de président du conseil d'administration et demeurera administrateur. M. Yarie est un géophysicien expérimenté et un entrepreneur minier à succès. Il possède plus de 25 ans d'expérience dans l'industrie à des postes de direction, fondant et dirigeant des entreprises au niveau national et international. Il est re...

 PRESS RELEASE

Atlas Lithium Secures US$ 30,000,000 Strategic Investment and Offtake ...

Boca Raton, Florida--(Newsfile Corp. - March 28, 2024) - (NASDAQ: ATLX), a lithium exploration and development company, is pleased to announce that it has signed definitive investment and offtake agreements with Mitsui & Co., Ltd. ("Mitsui") which the Company considers as strong validation of its project and team. Mitsui is purchasing US$ 30,000,000 in common shares of Atlas Lithium at a 10% premium to the 5-day VWAP (the "Strategic Investment") and at the same time entering into an Offtake Agreement (the "Offtake") for the future purchase of 15,000 tons of lithium concentrate from Phase 1 an...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch